Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.807 | 0.240 | 6 | 36026129 | upstream gene variant | A/G | snv | 0.14 |
|
0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
0.807 | 0.240 | 6 | 36026129 | upstream gene variant | A/G | snv | 0.14 |
|
Nutritional and Metabolic Diseases; Immune System Diseases; Endocrine System Diseases | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.807 | 0.240 | 6 | 36026129 | upstream gene variant | A/G | snv | 0.14 |
|
0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
0.807 | 0.240 | 6 | 36026129 | upstream gene variant | A/G | snv | 0.14 |
|
Skin and Connective Tissue Diseases; Endocrine System Diseases; Cardiovascular Diseases | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.807 | 0.240 | 6 | 36026129 | upstream gene variant | A/G | snv | 0.14 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.807 | 0.240 | 6 | 36026129 | upstream gene variant | A/G | snv | 0.14 |
|
Nervous System Diseases | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.807 | 0.240 | 6 | 36026129 | upstream gene variant | A/G | snv | 0.14 |
|
Nervous System Diseases | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.807 | 0.240 | 6 | 36030611 | intron variant | C/G;T | snv |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
0.807 | 0.240 | 6 | 36030611 | intron variant | C/G;T | snv |
|
Nervous System Diseases | 0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
0.807 | 0.240 | 6 | 36030611 | intron variant | C/G;T | snv |
|
0.700 | 1.000 | 1 | 2017 | 2017 | |||||||||
|
0.807 | 0.240 | 6 | 36030611 | intron variant | C/G;T | snv |
|
Nutritional and Metabolic Diseases; Immune System Diseases; Endocrine System Diseases | 0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
0.807 | 0.240 | 6 | 36030611 | intron variant | C/G;T | snv |
|
Skin and Connective Tissue Diseases; Endocrine System Diseases; Cardiovascular Diseases | 0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
0.807 | 0.240 | 6 | 36030611 | intron variant | C/G;T | snv |
|
0.700 | 1.000 | 1 | 2017 | 2017 | |||||||||
|
0.807 | 0.240 | 6 | 36030611 | intron variant | C/G;T | snv |
|
Nervous System Diseases | 0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
1.000 | 0.080 | 6 | 36041718 | intron variant | A/G | snv | 4.2E-02 |
|
Chemically-Induced Disorders; Mental Disorders | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||
|
1.000 | 0.040 | 6 | 36109157 | 3 prime UTR variant | G/A | snv | 8.6E-02 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||||
|
1.000 | 0.040 | 6 | 36100526 | intron variant | G/A | snv | 0.14 |
|
Musculoskeletal Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.080 | 6 | 36102610 | missense variant | A/G | snv | 1.2E-05 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.925 | 0.080 | 6 | 36038443 | intron variant | G/A | snv | 0.89 |
|
Neoplasms; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.925 | 0.080 | 6 | 36038443 | intron variant | G/A | snv | 0.89 |
|
Neoplasms; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 |